$IFF

International Flavors & Fragrances (NYSE:IFF) Misses Q2 CY2026 Sales Expectations and Lowers CY Guidance

International Flavors & Fragrances (NYSE:IFF) reported Q2 CY2026 sales of $1.95 billion, down 29.3% year on year, missing Wall Street expectations. The company lowered full-year revenue guidance to $7.5 billion at the midpoint, about 30.2% below analysts’ estimates. Non-GAAP EPS was $0.82, 26.6% below consensus.

Original reporting
Published Aug 4, 2026, 10:41 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 11:02 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
International Flavors & Fragrances (NYSE:IFF) Misses Q2 CY2026 Sales Expectations and Lowers CY Guidance — source image
Decision brief

The 30-second read

$IFFBearishMed
01

Why it matters

Q2 CY2026 results show a sharp YoY revenue decline and a full-year revenue guidance midpoint that is materially below sell-side expectations, alongside weaker non-GAAP EPS versus consensus.

02

Market read

This is a guidance reset with quantified misses on revenue and EPS, which typically drives estimate revisions and near-term positioning changes.

03

What to watch

The text emphasizes cash flow margin improvement and seasonal FCF swings; traders may be over-weighting the revenue decline versus profitability and cash generation trends.

Relevance 8/10Novelty 8/10Timing: after-hours/late-day following Q2 results and lowered CY guidance

Background

IFF is a flavor and fragrance ingredient supplier serving food, beverage, personal care, and pharma end markets.

Company-level read

Ticker impact

$IFFBearishMedium confidence
Context

IFF reported Q2 CY2026 revenue of $1.95B, down 29.3% YoY, and guided full-year revenue to $7.5B midpoint, below estimates.

Expected impact

Near-term bearish bias; traders may fade rallies or reduce exposure ahead of any management commentary or subsequent estimate revisions.

Evidence & confidence

The article provides concrete downside datapoints: revenue down 29.3% YoY, full-year revenue guidance 30.2% below analysts’ estimates, and non-GAAP EPS 26.6% below consensus. It also notes the stock was flat immediately after results, suggesting the market may already be digesting the news but guidance shortfall can still drive revisions.

Market effects

A consumer staples ingredient supplier’s guidance reset can weigh on sentiment for defensives tied to discretionary-adjacent end markets (personal care, food ingredients).

Primarily US-listed sentiment impact; limited direct regional spillover beyond US consumer staples/ingredients peers.

Global read-across for flavor and fragrance demand expectations, but the article is company-specific with no broader macro linkage.

Counterpoint

The article highlights organic revenue outperformance versus estimates and a large gross margin beat, which could indicate the revenue miss is not purely structural and may stabilize if demand normalizes.

Key entities

  • International Flavors & Fragrances

    Reported Q2 CY2026 revenue miss and lowered full-year revenue guidance; non-GAAP EPS also below consensus.

Related articles

$IFFMed

Why International Flavors & Fragrances (IFF) Is Up 6.4% After New $2.5 Billion Buyback And Guidance

International Flavors & Fragrances (IFF) reported Q2 2026 sales of US$1,954 million and net income of US$50 million, with full-year guidance updated for discontinued operations. The company also authorized a new US$2.5 billion share repurchase and reaffirmed its quarterly dividend. The article links the buyback and portfolio reshaping to IFF’s risk and cash-generation outlook.

$IFFMed

Why is International Flavors & Fragrances stock climbing today?

International Flavors & Fragrances (IFF) shares rose 0.8% in pre-open trading. The company said it will sell its Food Ingredients business to CVC Capital Partners for about $4.3 billion, expected to close by end of Q2 2027, and announced a $2.5 billion share repurchase. Q2 adjusted EPS was $0.82 vs $1.09 expected, revenue $1.95B vs $2.68B, but core results improved. Oppenheimer raised its IFF price target to $95 from $90.

$IFFMed

International Flavors & Fragrances (IFF) Jumps 8.4% to $87.67

International Flavors & Fragrances (IFF) shares rose 8.4% to $87.67 on Wednesday after the company announced a $2.5 billion stock buyback, despite a second-quarter earnings miss, according to the report. The article says investors viewed the repurchase and portfolio transformation as confidence in future performance. Trading volume was 683,126 shares.

$IFFMedAI 8/10

IFF Cut Its 2026 Outlook After A Rough Quarter

International Flavors and Fragrances (IFF) cut its 2026 outlook after a weak quarter. Q2 revenue fell to $1.95B versus $2.69B expected, and adjusted EPS was 82 cents versus $1.12. Sales in its Health and Biosciences unit were $601M. IFF sold its Food Ingredients unit to CVC Capital Partners for about $4.3B and now expects 2026 sales of $7.4B-$7.6B and adjusted operating core profit of $1.53B-$1.60B.